Biotechnology

Filter

Current filters:

None

Popular Filters

1 to 25 of 2554 results

Ohr Pharma plunges as wet-AMD drug fails to meet endpoint

27-03-2015

Ohr Pharmaceutical has said a Phase II study of its OHR-102 (0.2% squalamine lactate ophthalmic solution)…

BiotechnologyLucentisOhr PharmaceuticalOHR-102OphthalmicsResearch

EMA validates Biogen and AbbVie’s Zinbryta MAA for multiple sclerosis

27-03-2015

The European Medicines Agency has validated the Marketing Authorization Application for US biotech firms…

AbbVieBiogenBiotechnologydaclizumabEuropeNeurologicalRegulationZinbryta

Novasep to supply ingredient for Celladon’s Mydicar

Novasep to supply ingredient for Celladon’s Mydicar

26-03-2015

French active ingredients company Novasep and US biotech firm Celladon Corp, a clinical-stage cardiovascular…

BiotechnologyCardio-vascularCelladonMydicarNovasepProduction

BioNano Genomics appoints Terry Salyer as chief commercial officer

BioNano Genomics appoints Terry Salyer as chief commercial officer

26-03-2015

Genome mapping specialist BioNano Genomics has appointed Terry Salyer as chief commercial officer.

BioNano GenomicsBiotechnologyBoardroomTerry SalyerUSA

Green Cross and Nanolek enter strategic partnership to commercialize biologics in Russia

Green Cross and Nanolek enter strategic partnership to commercialize biologics in Russia

26-03-2015

South Korean biopharma company Green Cross and Russian drugmaker Nanolek have entered into a strategic…

BiotechnologyGreen CrossLicensingMarkets & MarketingNanolekRussia

Signum Dermalogix licenses SIG990 to Dermata Therapeutics for rosacea

Signum Dermalogix licenses SIG990 to Dermata Therapeutics for rosacea

25-03-2015

Dermatology biotech company Signum Dermalogix has entered into an agreement with Dermata Therapeutics…

BiotechnologyDermatologicalsLicensingResearchSignum Dermalogix

Semma Therapeutics secures $44 million funding to develop diabetes cell therapy

25-03-2015

USA-based biotech start-up Semma Therapeutics, which is developing a cell therapy for type 1 diabetes,…

BiotechnologyDiabetesFinancialNovartisResearchSemma Therapeutics

Lpath's Asonep fails to meet primary endpoint at Phase IIa; shares slide

Lpath's Asonep fails to meet primary endpoint at Phase IIa; shares slide

25-03-2015

Lpath says that its investigational therapy Asonep (sonepcizumab) did not meet the primary endpoint in…

AsonepBiotechnologyLpathOncologyResearch

Bristol-Myers acquires rights to Novo Nordisk program focused on autoimmune diseases

Bristol-Myers acquires rights to Novo Nordisk program focused on autoimmune diseases

24-03-2015

US pharma major Bristol-Myers Squibb has agreed to acquire from Danish diabetes care giant Novo Nordisk…

BiotechnologyBristol-Myers SquibbGlobalImmunologicalsLicensingNovo Nordisk

Merck halts Keytruda study on positive results in melanoma

24-03-2015

US pharma giant Merck & Co says it will discontinue a study of its cancer drug Keytruda (pembrolizumab)…

BiotechnologyKeytrudaMerck & CoOncologyResearch

Ono Pharma gets South Korea approval of Opdivo

24-03-2015

Japanese drugmaker Ono Pharmaceutical has received approval from South Korea’s Ministry of Food and…

BiotechnologyBristol-Myers SquibbOncologyOno PharmaceuticalOpdivoRegulationSouth Korea

Janssen acquires UK virtual biopharma firm XO1

24-03-2015

US health care giant Johnson & Johnson subsidiary Janssen Pharmaceuticals, has acquired XO1 Limited,…

BiotechnologyCardio-vascularichorcumabJanssenJohnson & JohnsonMergers & AcquisitionsUKXO1 Limited

Cardio3 Biosciences opens US manufacturing facility

Cardio3 Biosciences opens US manufacturing facility

24-03-2015

European cell therapy specialist Cardio3 BioSciences is to open a new USA-based manufacturing facility…

BiotechnologyCardio3 BioSciencesCardio3 BioSciencesProductionUSA

Regenerative Medicine Expert Group publishes report with action plan for UK implementation

Regenerative Medicine Expert Group publishes report with action plan for UK implementation

24-03-2015

The Regenerative Medicine Expert Group has published its report ‘Building on our own potential: a UK…

BiotechnologyPricingRegulationResearchUK

Takeda in-licenses ImmunoGen’s antibody-drug conjugate technology

Takeda in-licenses ImmunoGen’s antibody-drug conjugate technology

23-03-2015

US biotech firm ImmunoGen (Nasdaq: IMGN) saw its shares leap 17% to $8.74 in early morning trading on…

BiotechnologyImmunoGenLicensingOncologyTakeda Pharmaceutical

GenVec collaborates with TheraBiologics on cancer therapeutics

GenVec collaborates with TheraBiologics on cancer therapeutics

23-03-2015

Gene therapy specialist GenVec has formed a collaboration with TheraBiologics to develop cancer therapeutics.

BiotechnologyGenVecOncologyResearchUSA

Biogen Idec rebrands as Biogen with new logo

Biogen Idec rebrands as Biogen with new logo

23-03-2015

US biotech firm Biogen Idec has rebranded as Biogen, introducing a new logo and corporate identity.

BiogenBiotechnologyBusiness FinanceIDECManagementUnited StatesUSA

Pfenex gets early HSR clearance for collaboration with Hospira

23-03-2015

The US Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino…

BiosimilarsBiotechnologyGenentechHospiraLicensingLucentisOphthalmicsPF582PfenexRegulationRocheUSA

IQWiG now finds added benefit for Provenge

23-03-2015

Reversing a previous negative opinion, the German Institute for Quality and Efficiency in Health Care…

BiotechnologyDendreonGermanyOncologyPricingProvengeRegulationValeant Pharmaceutical International

Indian government moves to jumpstart domestic biotech sector

23-03-2015

Hyderabad, India-based Bharat Biotech's first novel vaccine, Rotavac, developed completely in the developing…

Bharat BiotechBiotechnologyFinancialIndiaResearchVaccines

Evotec signs 250 million-euro major multi-component alliance with Sanofi

Evotec signs 250 million-euro major multi-component alliance with Sanofi

21-03-2015

German biotech company Evotec said on Friday that a definitive agreement for a major multi-component…

BiotechnologyEvotecSanofi

Farmaindustria defends the non-interchangeability principle for biologic and biosimilar medicines

21-03-2015

Speaking at the first Biological Medicines Forum organized by the Associations last week, the president…

BiosimilarsBiotechnologyPatents & Trade marksRegulationSpain

1 to 25 of 2554 results

Back to top